BioCentury
ARTICLE | Clinical News

REG1 Anticoagulation System: Phase IIb started

September 14, 2009 7:00 AM UTC

Regado began the double-blinded reversal, active-controlled, dose-ranging, international Phase IIb RADAR trial to compare REG1 vs. unfractionated heparin or low molecular weight heparin in 800 ACS pat...